Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to test the effectiveness of Obeticholic Acid when used in patients with moderately severe alcoholic hepatitis. The researchers suspect that individuals with alcoholi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Naga P. Chalasani
Collaborators
NCT04088370 · Alcoholic Hepatitis
NCT06159244 · Severe Acute Alcoholic Hepatitis, Alcohol, and more
NCT06919458 · Alcoholic Hepatitis
NCT02344680 · Human Immunodeficiency Virus, HBV, and more
NCT06285253 · Acute Liver Failure, Acute Liver Injury, Drug Induced, and more
Indiana University
Indianapolis, Indiana
Mayo Clinic
Rochester, Minnesota
Einstein Healthcare Network
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions